Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Newegg Commerce Inc (NEGG) vs Twist Bioscience Corp (TWST) Price & Performance

Newegg Commerce IncTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Newegg Commerce Inc vs Twist Bioscience Corp — how do they compare? Newegg Commerce Inc trades at $11.7 (market cap $243.30M), while Twist Bioscience Corp trades at $160.15 (market cap $10.08B). The key difference: Twist Bioscience Corp is far larger — about 41.4× Newegg Commerce Inc's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Newegg Commerce Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Newegg Commerce Inc for 14 Days and Twist Bioscience Corp for 27 Days on average.

NEGGTWST
Market Cap
$243.30M$10.08B
Volume
41,2524,229,037
Sector
Consumer CyclicalHealth
52-Week High
$92.74$205.00
52-Week Low
$11.49$25.45
Typical Hold Time
14 Days27 Days
Enterprise Value
$213.53M$10.01B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Newegg Commerce Inc

NEGG trades at $11.69, down 2.66% today, with a bearish technical signal from moving averages but oversold RSI readings. The company shows improving fundamentals with revenue stabilizing around $1.4B and net losses narrowing significantly from -$59M in 2023 to -$4.88M in 2025. Recent earnings beats and strategic partnerships with Western Digital and HPE highlight operational progress, though negative operating cash flow and insider selling present concerns.

The outlook remains mixed with improving profitability trends but significant execution risks. Valuation appears reasonable with P/S of 0.18x, but analyst consensus target of $7.75 suggests 34% downside. Key risks include competitive e-commerce pressures and the need to sustain recent operational improvements amid challenging market conditions.

Twist Bioscience Corp

Twist Bioscience (TWST) trades at $162.43, up 4.36% today, showing strong momentum despite recent earnings misses. The stock maintains a bullish technical signal with RSI at 29.02 indicating potential oversold conditions. Fundamentally, revenue growth continues (2025: $377M, 2026: $432M projected) but profitability remains elusive with negative margins. Recent partnership with Eli Lilly's TuneLab platform highlights strategic positioning in AI-driven drug discovery.

While analyst consensus favors Buy (73%), the stock trades above the $145.20 target, suggesting limited near-term upside. Key risks include persistent cash burn (-$44M net CF in 2025) and high valuation multiples (P/S: 21.5). The AI biotech partnership provides growth catalyst potential, but profitability timeline remains uncertain for investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NEGG
25% Buy75% Sell
Avg holding period · 14 Days
TWST
100% Buy0% Sell
Avg holding period · 27 Days

Top news

Latest headlines on both assets

About Newegg Commerce Inc

Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.

Read more on NEGG →

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST →